AmMax Bio Announces First Patient Dosed in Phase 2a Study Evaluating AMB-066 in Patients with Colorectal Cancer Minimal Residual Disease
AMB-066 is a potential first-in-class treatment for CRC MRD ~20,000 patients diagnosed annually in U.S.; no currently approved therapies ...
Norlase Receives FDA 510(k) Clearance and CE Mark for LYNX Pattern Scanning Laser Indirect Ophthalmoscope
Introducing the World's First LIO with Integrated Pattern Scanning Capabilities BALLERUP, Denmark and REDWOOD CITY, Calif., ...
Le Lézard53m
Norlase Receives FDA 510(k) Clearance and CE Mark for LYNXtm Pattern Scanning Laser Indirect Ophthalmoscope
Norlase, a leading global ophthalmic laser manufacturer developing next-generation laser solutions, today announced the ...
San Mateo Daily Journal1h
Creativity hub finds home in Redwood City
A new hub for creatives throughout the county will soon fill the historic walls of Hotel Sequoia in Redwood City, ...